Figure 3.
Figure 3. Outcome after HSCT for sickle cell anemia. The Kaplan-Meier probabilities of survival, event-free survival, and a cumulative incidence curve for graft rejection/recurrent sickle cell disease are shown. Fifty patients who had at least 6 months follow-up received matched sibling marrow allografts between September 1991 and October, 1999.

Outcome after HSCT for sickle cell anemia. The Kaplan-Meier probabilities of survival, event-free survival, and a cumulative incidence curve for graft rejection/recurrent sickle cell disease are shown. Fifty patients who had at least 6 months follow-up received matched sibling marrow allografts between September 1991 and October, 1999.

Close Modal

or Create an Account

Close Modal
Close Modal